Advances in genomics, clinical diagnostic methods and therapies are now fueling healthcare. By integrating clinical data and genetic information, healthcare providers can improve population screening, diagnosis, prognosis, risk management, and in some cases, offer new and innovative targeted therapy for conditions such as cardiovascular diseases, lipid disorders, diabetes, cancer, among many other clinically complex morbidities.
The International Center for Genetic Disease (ICGD) has been established at the Brigham and Women’s Hospital with the goal of functioning as a collaborative platform for investigating genetic diseases in different populations.
The BWH International Center for Genetic Disease brings together clinicians, scientists, and patients from different parts of the world to discover the genetic causes of disease and translate these discoveries into improved diagnoses, treatments, and prevention strategies.
scientists at the iCGD aim to make advances leading that change the future of
precision and genomic medicine.
Identifying novel disease genes underlying genetic conditions.
Devising improved or novel diagnostics or treatments.
Promote the implementation of genomic and precision medicine in BWH, MGH, Broad Institute and Middle East through capacity building.